FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087824505> ?p ?o ?g. }

• W2087824505 endingPage "139" @default.
• W2087824505 startingPage "125" @default.
• W2087824505 abstract "A number of immunomodulating agents of different origin have been shown to reduce liver injury of various etiologies. Immunostimulants like levamisole, BCG, a protein polysaccharide from myceria Coriolus vesicolor PS-K, a streptoccocal preparation OK-432 and immunomodulators like N-acetylmuramyl-l-alanyl-disoglutamine (MDP) and its analogs. Selective T-cell suppressors like the polypeptide cyclosporine A (CsA) and the macrolide FK 506 (tacrolimus) have also been claimed to possess hepatoprotrophic or hepatoprotective properties at low doses. The aim of this review article is to highlight the interplay between the administration of immunomodulating agents and the amelioration of hepatic injuries. Hepatic effects of exogenous immunomodulators are discussed with special focus on the most widely used immunosuppressive agents, CsA and tacrolimus. An important question exists as to whether these potential hepatoprotective effects are related mechanistically to the immune system or are working at different levels. Due to the differences in effects and modes of actions of various immunoactive substances presented herein, a common mechanism for their cytoprotective effects cannot be formulated at this stage. Levamisole and cyanidanol may protect cells against necrosis by acting as free radical scavengers. MDP and its analogs reduce carbon tetrachloride-elevated (CC14) lipid peroxides and their protective effects are primarily on hepatic cytoplasmic membranes where lipid peroxidation and calcium homeostasis interact. MDP reduced CC14-elevated calcium in both intact hepatocytes and in the post microsomal supernatant suggest that the influx of extracellular calcium across plasma membrane is affected. Elevations of intracellular calcium above a threshold are involved in: the stimulation of Ca2-sensitive enzymes such as phospholipase A2, endonucleases and proteases, the conversion of xanthine dehydrogenase to xanthine oxidase and the formation of free radicals, all of which disturb biomembranes. MDP and its analogs, in a specific dose range, may act to maintain intracellular calcium within physiological ranges. Highly complex cellular signalling systems, including calcium, are involved in the explanation of the mechanism of the immunosuppressive effect of CsA and tacrolimus. The hepatoprotective effects of these selective immunosuppressive agents, however, are independent of the inhibition of T-cell activation. The cyclophilin and tacrolimus binding proteins of the mitochondria are the receptors for these compounds and play a key role in the regulation of mitochondrial permeability transition pores. CsA or tacrolimus inhibition of mitochondrial permeability transition pores does not require interaction with calcineurin, indicating a dissociation between immunosuppression and mitochondrial protection. The involvement of intracellular or intramitochondrial proteins in the modulation of mitochondrial permeability transition pores with the creation of a partially impermeable state for Ca2 movement in drug-treated mitochondria and the dissociation of this effect from immunomodulatory actions potentially offers new and promising approaches for the development of new pharmacologicals targeted at therapeutic intervention. Clinical trials of these drugs as hepatoprotective agents are limited. Use of CsA in patients with primary biliary cirrhosis and autoimmune chronic hepatitis and in cirrhotic animal models produced by chronic administration of CC14 have yielded encouraging results. It seems that this class of compounds may be of substantial benefit in liver protection against many pathological conditions where disturbance in mitochondrial function and in Ca2 homeostasis appear to be prerequisites for cell injury." @default.
• W2087824505 created "2016-06-24" @default.
• W2087824505 creator A5002459969 @default.
• W2087824505 creator A5025103425 @default.
• W2087824505 date "1998-08-01" @default.
• W2087824505 modified "2023-09-27" @default.
• W2087824505 title "Immunopharmacologic agents in the amelioration of hepatic injuries" @default.
• W2087824505 cites W1500094754 @default.
• W2087824505 cites W1548077438 @default.
• W2087824505 cites W1568357466 @default.
• W2087824505 cites W1593547522 @default.
• W2087824505 cites W1967315269 @default.
• W2087824505 cites W1968498522 @default.
• W2087824505 cites W1971863839 @default.
• W2087824505 cites W1972229497 @default.
• W2087824505 cites W1973637116 @default.
• W2087824505 cites W1973812004 @default.
• W2087824505 cites W1974025159 @default.
• W2087824505 cites W1974426823 @default.
• W2087824505 cites W1984947099 @default.
• W2087824505 cites W1986033409 @default.
• W2087824505 cites W1993625835 @default.
• W2087824505 cites W1996867825 @default.
• W2087824505 cites W1997599102 @default.
• W2087824505 cites W1999361201 @default.
• W2087824505 cites W2000992025 @default.
• W2087824505 cites W2005873886 @default.
• W2087824505 cites W2007005170 @default.
• W2087824505 cites W2009032298 @default.
• W2087824505 cites W2011673927 @default.
• W2087824505 cites W2016063936 @default.
• W2087824505 cites W2024139423 @default.
• W2087824505 cites W2025421728 @default.
• W2087824505 cites W2026645232 @default.
• W2087824505 cites W2027165619 @default.
• W2087824505 cites W2027865643 @default.
• W2087824505 cites W2029805256 @default.
• W2087824505 cites W2036688919 @default.
• W2087824505 cites W2043360695 @default.
• W2087824505 cites W2044430823 @default.
• W2087824505 cites W2047606730 @default.
• W2087824505 cites W2049231196 @default.
• W2087824505 cites W2054277015 @default.
• W2087824505 cites W2055681196 @default.
• W2087824505 cites W2058137293 @default.
• W2087824505 cites W2061811073 @default.
• W2087824505 cites W2061856623 @default.
• W2087824505 cites W2066723587 @default.
• W2087824505 cites W2080204709 @default.
• W2087824505 cites W2081900675 @default.
• W2087824505 cites W2084926712 @default.
• W2087824505 cites W2085665934 @default.
• W2087824505 cites W2086263833 @default.
• W2087824505 cites W2090308278 @default.
• W2087824505 cites W2106087915 @default.
• W2087824505 cites W2130436432 @default.
• W2087824505 cites W2133218402 @default.
• W2087824505 cites W2138110179 @default.
• W2087824505 cites W2148850683 @default.
• W2087824505 cites W2158272509 @default.
• W2087824505 cites W2318087828 @default.
• W2087824505 cites W2336806052 @default.
• W2087824505 cites W2395326541 @default.
• W2087824505 cites W2421191313 @default.
• W2087824505 cites W4234098118 @default.
• W2087824505 cites W4238919352 @default.
• W2087824505 cites W4247876752 @default.
• W2087824505 cites W7751259 @default.
• W2087824505 doi "https://doi.org/10.1016/s0192-0561(98)00023-x" @default.
• W2087824505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9730249" @default.
• W2087824505 hasPublicationYear "1998" @default.
• W2087824505 type Work @default.
• W2087824505 sameAs 2087824505 @default.
• W2087824505 citedByCount "19" @default.
• W2087824505 countsByYear W20878245052012 @default.
• W2087824505 countsByYear W20878245052014 @default.
• W2087824505 countsByYear W20878245052015 @default.
• W2087824505 countsByYear W20878245052016 @default.
• W2087824505 countsByYear W20878245052022 @default.
• W2087824505 crossrefType "journal-article" @default.
• W2087824505 hasAuthorship W2087824505A5002459969 @default.
• W2087824505 hasAuthorship W2087824505A5025103425 @default.
• W2087824505 hasConcept C178790620 @default.
• W2087824505 hasConcept C181080969 @default.
• W2087824505 hasConcept C185592680 @default.
• W2087824505 hasConcept C202751555 @default.
• W2087824505 hasConcept C203014093 @default.
• W2087824505 hasConcept C2776200302 @default.
• W2087824505 hasConcept C2777359374 @default.
• W2087824505 hasConcept C2778004101 @default.
• W2087824505 hasConcept C2780829032 @default.
• W2087824505 hasConcept C2781325985 @default.
• W2087824505 hasConcept C519063684 @default.
• W2087824505 hasConcept C55493867 @default.
• W2087824505 hasConcept C71924100 @default.
• W2087824505 hasConcept C79879829 @default.
• W2087824505 hasConcept C8891405 @default.
• W2087824505 hasConcept C98274493 @default.

• next